SEC Form 4 · accession 0001127602-15-007601
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy J Hutson
Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 23, 2015 · 12:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | P | 10,000 | $10.27 | A | 15,891 | D |
Table II — derivative securities
No Table II lines on this filing.